Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs fluticasone for red face atopic dermatitis
2004-002477-23Phase 4Completed
- Sponsor
- Fujisawa Pharmaceutical
- Start
- Feb 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Envarsus XR in atopic dermatitis (AD) (2 arms), sponsored by Fujisawa Pharmaceutical. Primary endpoint: Facial mLEASI score at week 3. Started Feb 2005; status: completed.
02
Drugs
Envarsus XR
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-002477-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002477-23.